Improved Glycemic Control for Prediabetes and/or Diabetes Type II using Docohexaenoic Acid

摘要

This invention is directed to methods for treating patients with metabolic syndrome, prediabetes and/or type II diabetes mellitus by administering docosahexanoic acid (DHA) alone or in combination with diabetes-related medicines.